NHS England reveals sites that will take forward redesign of NHS careNHS England has announced the 29 sites that will take the lead in providing new models of care envisaged in the NHS Five Year Forward View published in October 2015.…
Rita Scanlon diesOn 19 February 2015, Rita Scanlon MRPharmS, aged 84, of 10 Scarborough Road, Shipley BD18 3DR. Miss Scanlon registered with the Society in 1954.…
Francis Jamieson diesOn 2 March 2015, Francis Jamieson MRPharmS, aged 83, of Hurstwood, The Manor House, Eyhurst Park, Tadworth KT20 6JR. Mr Jamieson registered with the Society in 1956.…
John Nicholas Staniforth diesOn 6 March 2015, John Nicholas Staniforth, aged 61, of The Byre, Claverton, Bath BA2 7BG. Mr Staniforth registered with the Society in 1976. He left the Society in 2014.…
Global alliance of pharmacy schools launched to boost joint researchA global alliance of pharmacy schools based in the UK, Australia and the United States has been launched to boost joint international research.…
RPS opposes Saatchi Bill6 March 2015: Royal Pharmaceutical Society president Ash Soni was a signatory to a letter published in The Times protesting against the Saatchi Bill. The letter stated: “What patients need is continued support for scientifically based medical research, but what they would get under this B…
Drug driving law comes into force2 March 2015: A new drug-driving law has come into force in England and Wales, which sets limits for eight illegal drugs and eight prescription drugs that could impair driving. Royal Pharmaceutical Society spokesperson Professor David Taylor, a member of the Department for Transport advisory p…
2015 elections to the national pharmacy boardsThe 2015 elections to the three national pharmacy boards are vitally important to the continued success of the Society, which depends on a vibrant, engaged and committed membership. All members and Fellows have an opportunity, through involvement in the election process, to participate …
EMA recommends treatment for rare kidney condition The European Medicines Agency has recommended the approval of tolvaptan for the treatment of a rare inherited disease, autosomal dominant polycystic kidney disease.…
AstraZeneca spins out early-stage R&D for antibiotic compoundsAstraZeneca is creating a standalone subsidiary to work exclusively on early-stage antibiotics research and development, the company has announced.…